• 생물정신의학
• /
• 제14권2호
• /
• pp.122-128
• /
• 2007

Objectives : The aim of this study was to investigate relationships between psychotic symptoms and cognitive functions in schizophrenia. Methods : The study group was composed of 36 schizophrenic patients. Positive, negative, and disorganization symptoms were assessed using the PANSS. Verbal, visuospatial, attention, memory, and executive functions were assessed using a battery of cognitive tests. Results : Correlation analysis between symptom vs. cognitive measures showed that (a) positive symptoms were significantly correlated with no cognitive measures, (b) negative symptoms were significantly correlated with all cognitive measures, and (c) disorganization symptoms were significantly correlated with executive and memory measures. Correlation analyses between symptom vs. cognitive factors showed that negative-disorganization factor is significantly correlated with executive-memory factor. Conclusion : Significant relationships were confined mostly to frontal symptoms vs. frontal cognitive functions. Thus, the relationships may be mediated mainly by variations in severity of frontal pathology among patients.

• 한국임상약학회지
• /
• 제34권2호
• /
• pp.118-125
• /
• 2024

Background: Numerous studies have consistently demonstrated that depression can be associated with cognitive function decline, primarily focusing on older adults due to the neurodegenerative characteristics of dementia. With persistent depression frequently reported in patients with early-onset or young-onset dementia, this study aimed to assess the impact of depression, specifically the changes in depressive symptoms over time, on the risk of cognitive function decline in middle-aged adults in Korea. Methods: This retrospective study utilized data from the first four waves (2006-2012) of the Korean Longitudinal Study of Aging (KLoSA), focusing on middle-aged adults with normal cognitive function at baseline. Changes in depressive symptoms were categorized into four groups based on the CES-D score, and their association with cognitive function decline was evaluated using a multivariate logistic regression model. Results: Of the initial 10,254 participants, 3,400 were included in the analysis. Depressive status, particularly newly onset (adjusted odds ratio [aOR] 1.96; 95% confidence interval [CI] 1.32-2.93) and persistent depression groups (aOR 5.59; 95% CI 2.90-10.78), were significantly associated with cognitive function decline. In contrast, recovery from depressive symptoms was not significantly associated with cognitive function decline (p=0.809). Conclusions: Our study showed a significant association between changes in depressive symptoms and cognitive function decline in middle-aged Korean adults. This suggests that management of depressive symptoms could be crucial for the prevention of cognitive function decline in this population.

• 생물정신의학
• /
• 제15권3호
• /
• pp.194-203
• /
• 2008

Objectives : This study was aimed at evaluating the relationship between somatic symptoms, depression, anxiety and cognitive function in the patients with Mild Traumatic Brain Injury(MTBI). Methods : Thirty seven patients with MTBI were selected from those patients who had visited the Department of Neuropsychiatry of Wonkwang University Hospital from 2003 to 2007. To assess and quantify the somatic symptoms, depression and anxiety, Personality Assessment Inventory(PAI) was used. Assessment of cognitive function was carried out by using Korean Wechsler Adult Intelligence Scale(K-WAIS), Rey-Kim Memory Test, and Kims Executive Function Test. The effects of somatic symptoms, depression, and anxiety on the cognitive function were evaluated by Pearson correlation test. Results : Somatic symptoms, depression, and anxiety, all showed inverse correlation to cognitive function. Specifically, 1) an increase in somatic symptoms was associated with a decrease in attention, verbal short term memory, verbal recall and recognition, and visual memory. 2) An increase in anxiety was associated with a decrease in verbal recall and recognition. 3) An increase in depression was associated with a decrease in cognitive function that requires high attention and verbal memory. Conclusion : The patients with MTBI displayed diverse symptoms ranging from cognitive impairment to somatic symptoms, depression, and anxiety. Somatic and emotional symptoms were correlated with cognitive function(especially executive function). Importantly, this study raises the possibility of treating the cognitive impairment associated with MTBI by treating somatic symptoms, depression, and anxiety.

• 대한간호학회지
• /
• 제53권4호
• /
• pp.453-467
• /
• 2023

Purpose: This study investigated the cumulative effects of depressive symptoms on cognitive function over time in community-dwelling older adults. Methods: Data were investigated from 2,533 community-dwelling older adults who participated in the Korean Longitudinal Study of Aging (KLoSA) from the 5th (2014) to the 8th wave (2020). The association between cumulative depressive symptoms and cognitive function was identified through multiple regression analysis. Results: When the multiple regression analysis was conducted from each wave, the current depressive symptoms scores and cognitive function scores were negatively associated, regardless of the waves (B5th = - 0.26, B6th = - 0.26, B7th = - 0.26, and B8th = - 0.27; all p < .001). Further, when all the previous depressive symptoms scores were added as explanatory variables in the 8th wave, the current one (B8th = - 0.09, p < .001) and the previous ones (B5th = - 0.11, B6th = - 0.09, and B7th = - 0.13; all p < .001) were also negatively associated with the cognitive function score. The delta R², which indicates the difference between the model's R² with and without the depressive symptoms scores, was greater in the model with all the previous and current depressive symptoms scores (6.4%) than in the model with only the current depressive symptoms score (3.6%). Conclusion: Depressive symptoms in older adults have a long-term impact. This results in an accumulated adverse effect on the cognitive function. Therefore, to prevent cognitive decline in older adults, we suggest detecting their depressive symptoms early and providing continuous intervention to reduce exposure to long-term depressive symptoms.

• 정신신체의학
• /
• 제29권1호
• /
• pp.42-48
• /
• 2021

연구목적 본 연구는 우울증의 동반증상으로 알려진 인지 기능 저하가 우울증보다 선행될 수 있다는 점에 착안하여 정상인에게서 우울 증상과 불안 증상이 인지 기능에 미치는 영향을 관찰하고자 한다. 방 법 일반인 50명을 모집하여 인지 기능 및 임상 증상에 대한 평가와 임상 증상이 인지 기능에 미치는 영향을 알아보기 위해 피어슨 상관분석과 다변량 회귀분석을 시행하였다. 우울증에서 흔히 저하되는 인지 영역을 평가하는 검사 소항목간의 상관성을 알아보기 위해 위해 소항목간 상관분석을 시행하였다. 결 과 선로잇기검사(B형)는 우울 증상(r=0.300, p=0.03)과 나이(r=0.323, p=0.02)와 상관 관계를 보였고 이에 영향을 미치는 독립변수는 우울 증상(β=0.304, p=0.03)과 나이(β=0.335, p=0.01)이며 선로잇기검사(B형)에 대해 14.8%의 설명력을 보여주었다. 주관적 인지 기능 검사는 불안 증상(r=0.434, p=0.002)과 상관 관계가 있었다. 인지 기능 소항목간 상관분석에서 주관적 인지 기능검사는 주의력검사를 제외한 나머지 항목과 상관 관계가 있었다. 결 론 본 연구에서 우울 증상은 나이, 교육기간 같은 인구학적 특성 외에 독립적으로 실행기능에 기여하는 것을 알 수 있었다. 우울증에서 인지 기능 저하가 흔한 장기적인 임상 결과임을 감안할 때 인지 기능에 대한 적극적인 조기 개입과 평가가 도움이 될 것으로 기대한다.

• 한국보건간호학회지
• /
• 제36권2호
• /
• pp.227-239
• /
• 2022

Purpose: This study aimed to examine the differences in the reciprocal causal relationship between cognitive function and depressive symptoms depending on whether older adults lived with others or alone. Methods: We used panel data retrieved from the sixth (Time 1) and seventh (Time 2) waves of the Korean Longitudinal Study of Aging (KLoSA). The study sample included 2,638 older adults living with others and 628 older adults living alone. We conducted cross-lagged panel analyses (CLPA) to identify the bidirectional causal relationship between cognitive function and depressive symptoms in the groups of older adults living with others and those living alone. Results: In the group of older adults living with others, cognitive function and depressive symptoms showed significant reciprocal relationships. In the group of older adults living alone, although the CLPA confirmed that higher levels of depressive symptoms at Time 1 influenced lower levels of cognitive function at Time 2, cognitive function at Time 1 was not associated with depressive symptoms at Time 2. Conclusion: The results suggest that the strategies for preventing cognitive decline and depressive symptoms should be developed according to whether the older adults live alone. Moreover, further studies should identify factors influencing depressive symptoms among older adults living alone, which will ultimately enable the management of depressive symptoms.

• 수면정신생리
• /
• 제11권1호
• /
• pp.44-49
• /
• 2004

목 적 : 만성 정신분열병 환자에서 양성증상과 음성증상의 호전이 인지기능에 어떤 영향을 끼치는 지를 알아보기 위함이다. 방 법：증상의 호전이 예상되는 활성기 정신분열병 환자 68명을 대상으로 입원 직후에 증상과 인지기능을 측정하고 6개월 약물치료 후 증상과 인지기능을 재차 측정하여 두 영역에서의 변화간의 연관성을 조사하였다. 또 약물치료에 의해 인지기능이 어느 수준까지 호전되는지를 알아보기 위하여 나이와 교육수준이 비슷한 정상 대조군 20명의 인지기능과도 비교하였다. 증상은 PANSS로 평가하였고, 인지기능은 고난도 지속수행검사를 이용한 지속적 주의력, 위스콘신 카드분류검사를 이용한 실행능력, 숫자 주의력을 이용한 주의 집중력, 그리고 레이 청각 언어성 학습검사를 이용한 언어성 기억과 학습 등을 측정하였다. 결 과：양성증상과 음성증상에서의 호전은 각 인지검사 점수의 변화에 유의한 영향을 미치지 않았고, 인지검사 점수의 변화에서 증상의 호전으로 설명될 수 있는 정도는 미미하였다. 또 정신분열병의 활성기에 비하여 6개월 약물치료 때의 관해기때 주의력, 실행능력, 기억력 모두 유의한 호전을 보였지만, 나이와 교육수준이 비슷한 정상대조군과 비교 시는 여전히 유의한 결손을 보였다. 결 론：이러한 결과는 정신분열병에서 증상과 인지기능이 서로 다른 영역일 가능성을 시사하며, 나아가 정신분열병 치료에 있어 증상의 호전뿐 아니라 인지기능의 호전에도 초점을 두어야 할 필요성을 부각시킨다.

• 사회복지연구
• /
• 제42권2호
• /
• pp.179-203
• /
• 2011

본 연구의 목적은 1) 노년기 인지기능과 우울증상의 양방적 상호관계를 분석하고, 2) 이 관계에서 성별차이를 검증하는 것이다. 이는 대부분의 기존연구가 인지기능과 우울증상의 일방적 관계를 가정한 것과 달리 상호영향력을 동시에 고려하고, 나아가 노년기 정신건강에서 성별에 따른 유의한 함의를 찾기 위함이다. 분석 자료는 우리나라의 중고령자를 대표하는 한국고령자패널 자료를 활용하였고, 분석 방법은 비재귀구조방정식모델(non-recursive structural equation modeling)과 다집단분석(multi-group analysis)을 실시하였다. 본 연구의 주요 결과는 다음과 같다. 첫째, 노년기 인지기능 저하가 우울증상을 악화시키고, 우울증상의 악화가 인지기능을 저하시키는 양방적 상호관계가 나타났다. 둘째, 인지기능과 우울증상의 관계에서 성별 차이가 명확히 나타났다. 여성노인에서는 우울증상에 대한 인지기능의 영향만 유의하였고, 남성노인에서는 인지기능에 대한 우울증상의 영향만 유의하였다. 이는 노년기 인지기능과 우울증상을 이해하고 관리함에 있어 상호영향력과 성별 차이를 고려한 접근이 필요함을 시사하는 결과이다. 이상의 결과가 노년기 정신건강에 대해 갖는 이론적 실천적 함의를 논의하였다.

• 성인간호학회지
• /
• 제29권2호
• /
• pp.200-210
• /
• 2017

Purpose: The purpose of this study was to assess the relationship between menopausal symptoms and decline in cognitive functioning of menopausal women with mediating effects of health promoting behavior. Methods: Using a convenience sampling, 140 menopausal women were recruited for the cross-sectional survey. Data were collected by using the Menopause Rating Scale, Health Promoting Lifestyle Profile, Everyday Cognition, and Korean Mini-Mental State Examination. Results: The mean scores for menopausal symptoms, health promotion behavior, and subjective cognitive decline were 14.40, 153.79, and 67.40 respectively. Health promotion behavior was directly affected by menopausal symptom ($R^2=8%$). Cognitive decline was directly affected by menopausal symptom ($R^2=11%$). Menopausal symptom (${\beta}=.33$, p<.001) and health promotion behavior (${\beta}=.21$, p=.014) were found to be predictive factors in subjective cognitive decline and explained 14%. Health promotion behavior had a partial mediating effect in the relationship between menopausal symptom and perceived cognitive decline (Sobel test: Z=2.05, p=.040). Conclusion: Based on the findings of this study, developing nursing intervention programs focusing on decreasing menopausal symptoms and encouraging health promotion behavior are recommended to improve cognitive decline in menopausal women.

• Clinical Psychopharmacology and Neuroscience
• /
• 제16권4호
• /
• pp.461-468
• /
• 2018

Objective: Cognitive disturbance is one of the major symptoms of depression and may be improved by treatment with antidepressants. This study aimed to investigate the predictors of cognitive improvement in patients with major depressive disorder (MDD) who were taking antidepressants. Methods: This study included 86 patients with MDD who completed 12 weeks of antidepressant monotherapy. Cognitive symptoms were assessed using the Perceived Deficits Questionnaire-Korean version (PDQ-K), which addresses four domains of cognitive functioning (attention/concentration, retrospective memory, prospective memory, and organization/planning) and was administered at study entry and at the 12-week end point. A variety of demographic, clinical, and treatment-related variables were evaluated as predictors of changes in total and domain scores. Results: All PDQ-K domains showed significant improvement after 12 weeks of antidepressant treatment. More severe initial depressive symptoms, fewer sick-leave days at study entry, and reduced use of concomitant anxiolytics/hypnotics during treatment were significantly associated with greater cognitive improvement. Conclusion: Cognitive symptoms are more responsive to antidepressant treatment in patients with severe MDD. Reduced use of anxiolytics and hypnotics could improve the cognitive functioning of patients with MDD taking antidepressants.